Assessment of disease progression in motor neuron disease

Lancet Neurology

Volumn 4, Issue 4, 2005, Pages 229-238

  Winhammar, Jennica M C ^a   Rowe, Dominic B ^a   Henderson, Robert D ^c   Kiernan, Matthew C ^b,d  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; N ACETYLASPARTIC ACID; SODIUM;

AMYOTROPHIC LATERAL SCLEROSIS; ANTERIOR HORN CELL; ARTERIAL OXYGEN TENSION; BRAIN BLOOD FLOW; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE SEVERITY; EVOKED MUSCLE RESPONSE; HUMAN; HYPERPOLARIZATION; LUNG FUNCTION TEST; MEDICAL ASSESSMENT; MEMBRANE STEADY POTENTIAL; MOTOR NEURON DISEASE; MUSCLE MASS; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE POTENTIAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; QUALITY OF LIFE; RATING SCALE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SODIUM CONDUCTANCE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 15044360151     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(05)70042-9     Document Type: Review

References (155)

1. MC Kiernan Motor neuron disease: a Pandora's box Med J Aust 178 2003 311 312
2. JJA Charcot Deux cas d'astrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero lateraux de la moelle epiniere Arch Physiol Neurol Pathol 2 1869 744 754
3. DR Rosen, T Siddique, D Patterson Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59 62
4. L Lacomblez, G Bensimon, PN Leigh, P Guillet, V Meininger Dose-ranging study of riluzole in amyotrophic lateral sclerosis Lancet 347 1996 1425 1431
5. WG Bradley, F Anderson, M Bromberg Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter Neurology 57 2001 500 504
6. Y Iwasaki, K Ikeda, M Kinoshita Molecular and cellular mechanism of glutamate receptors in relation to amyotrophic lateral sclerosis Curr Drug Target CNS Neurol Disord 1 2002 511 518
7. RG Miller, JD Mitchell, M Lyon, DH Moore Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Amyotroph Lateral Scler Other Motor Neuron Disord 4 2003 191 206
8. RJ Davenport, RJ Swingler, AM Chancellor, CP Warlow Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register J Neurol Neurosurg Psychiatry 60 1996 147 151
9. H Mitsumoto, DA Chad, EP Pioro Terminology and classification of ALS Amyotrophic lateral sclerosis 1998 FA Davis Company Philadelphia 3 15
10. SP Ringel, JR Murphy, MK Alderson The natural history of amyotrophic lateral sclerosis Neurology 43 1993 1316 1322
11. P Talman, S Mathers, E Mostert, A Forbes Evaluation of clinical patterns and rate of progression of motor neuron disease Amyotroph Lateral Scler Other Motor Neuron Disord 3 2002 93
12. A Czaplinski, AJ Steck, PM Andersen, M Weber Flail arm syndrome: a clinical variant of amyotrophic lateral sclerosis Eur J Neurol 11 2004 567 568
13. MT Hu, CM Ellis, A Al-Chalabi, PN Leigh, CE Shaw Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis J Neurol Neurosurg Psychiatry 65 1998 950 951
14. BR Brooks El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis J Neurol Sci 124 1994 96 107
15. RG Miller, TL Munsat, M Swash, BR Brooks Consensus guidelines for the design and implementation of clinical trials in ALS J Neurol Sci 169 1999 2 12
16. BJ Traynor, MB Codd, B Corr, C Forde, E Frost, M Hardiman Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House Diagnostic Criteria Arch Neurol 57 2000 1171 1176
17. MA Ross, RG Miller, L Berchert Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria Neurology 50 1998 768 772
18. E Beghi, C Balzarini, G Bogliun Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis Neuroepidemiology 21 2002 265 270
19. A Chio, G Mora, M Leone Early symptom progression rate is related to ALS outcome: a prospective population-based study Neurology 59 2002 99 103
20. C Bouchard, C Lacroix, V Plante Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy Neurology 52 1999 498 503
21. RJ Barohn, JT Kissel, JR Warmolts, JR Mendell Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria Arch Neurol 46 1989 878 884
22. FT Rotta, AT Sussman, WG Bradley, D Ram Ayyar, KR Sharma, RT Shebert The spectrum of chronic inflammatory demyelinating polyneuropathy J Neurol Sci 173 2000 129 139
23. N Latov Diagnosis of CIDP Neurology 59 2002 S2 S6
24. G Roth, J Rohr, MR Magistris, F Ochsner Motor neuropathy with proximal multifocal persistent conduction block, fasciculations, and myokymia: evolution to tetraplegia Eur Neurol 25 1986 416 423
25. GJ Parry, S Clarke Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease Muscle Nerve 11 1988 103 107
26. A Pestronk, DR Cornblath, AA Ilyas A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside Ann Neurol 24 1988 73 78
27. A Pestronk, V Chaudhry, EL Feldman Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies Ann Neurol 27 1990 316 326
28. P Bouche, A Moulonguet, AB Younes-Chennoufi Multifocal motor neuropathy with conduction block: a study of 24 patients J Neurol Neurosurg Psychiatry 59 1995 38 44
29. BV Taylor, RA Wright, CM Harper, PJ Dyck Natural history of 46 patients with multifocal motor neuropathy with conduction block Muscle Nerve 23 2000 900 908
30. MC Kiernan, JM Guglielmi, R Kaji, NM Murray, H Bostock Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block Brain 125 2002 664 675
31. K Hirayama, T Tsubaki, Y Toyokura, S Okinaka Juvenile muscular atrophy of unilateral upper extremity Neurology 13 1963 373 380
32. AV Krishnan, R Pamphlett, D Burke, MC Kiernan Cytoplasmic-body myopathy masquerading as motor neurone disease Muscle Nerve 30 2004 667 672
33. M Swash, M de Carvalho The neurophysiological index in ALS Amyotroph Lateral Scler Other Motor Neuron Disord 5 2004 108 110
34. M de Carvalho, M Scotto, A Lopes, M Swash Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis Muscle Nerve 28 2003 630 633
35. R Colombo, L Mazzini, G Mora Measurement of isometric muscle strength: a reproducibility study of maximal voluntary contraction in normal subjects and amyotrophic lateral sclerosis patients Med Eng Phys 22 2000 167 174
36. JM Shefner Motor unit number estimation in human neurological diseases and animal models Clin Neurophysiol 112 2001 955 964
37. C Lomen-Hoerth, MP Slawnych Statistical motor unit number estimation: from theory to practice Muscle Nerve 28 2003 263 272
38. H Santo Neto, VC de Carvalho, MJ Marques Estimation of the number and size of human flexor digiti minimi muscle motor units using histological methods Muscle Nerve 21 1998 112 114
39. K Arasaki, M Tamaki, Y Hosoya, N Kudo Validity of electromyograms and tension as a means of motor unit number estimation Muscle Nerve 20 1997 552 560
40. AJ McComas, PR Fawcett, MJ Campbell, RE Sica Electrophysiological estimation of the number of motor units within a human muscle J Neurol Neurosurg Psychiatry 34 1971 121 131
41. V Galea, H de Bruin, R Cavasin, AJ McComas The numbers and relative sizes of motor units estimated by computer Muscle Nerve 14 1991 1123 1130
42. RB Stein, JF Yang Methods for estimating the number of motor units in human muscles Ann Neurol 28 1990 487 495
43. DW Stashuk, TJ Doherty, A Kassam, WF Brown Motor unit number estimates based on the automated analysis of F-responses Muscle Nerve 17 1994 881 890
44. MB Bromberg Motor unit estimation: reproducibility of the spike-triggered averaging technique in normal and ALS subjects Muscle Nerve 16 1993 466 471
45. KJ Felice Thenar motor unit number estimates using the multiple point stimulation technique: reproducibility studies in ALS patients and normal subjects Muscle Nerve 18 1995 1412 1416
46. FC Wang, PJ Delwaide Number and relative size of thenar motor units in ALS patients: application of the adapted multiple point stimulation method Electroencephalogr Clin Neurophysiol 109 1998 36 43
47. HS Neto, JM Filho, R Passini Jr, MJ Marques Number and size of motor units in thenar muscles Clin Anat 17 2004 308 311
48. JR Daube Estimating the number of motor units in a muscle J Clin Neurophysiol 12 1995 585 594
49. C Lomen-Hoerth, RK Olney Comparison of multiple point and statistical motor unit number estimation Muscle Nerve 23 2000 1525 1533
50. JM Shefner, D Jillapalli, DY Bradshaw Reducing intersubject variability in motor unit number estimation Muscle Nerve 22 1999 1457 1460
51. RD Henderson, R McClelland, JR Daube Effect of changing data collection parameters on statistical motor unit number estimates Muscle Nerve 27 2003 320 331
52. JM Shefner, ME Cudkowicz, H Zhang, D Schoenfeld, D Jillapalli The use of statistical MUNE in a multicenter clinical trial Muscle Nerve 30 2004 463 469
53. C Armon, ME Brandstater Motor unit number estimate-based rates of progression of ALS predict patient survival Muscle Nerve 22 1999 1571 1575
54. KJ Felice A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis Muscle Nerve 20 1997 179 185
55. RD Henderson, PA McCombe, GR Ridall, AN Pettitt Bayesian statistics for estimating motor unit numbers Neurology 62 2004 455
56. D Burke, MC Kiernan, H Bostock Excitability of human axons Clin Neurophysiol 112 2001 1575 1585
57. H Bostock, MK Sharief, G Reid, NM Murray Axonal ion channel dysfunction in amyotrophic lateral sclerosis Brain 118 1995 217 225
58. MKR Kodawa, Y Kojima Threshold electronus in patients with amyotrophic lateral sclerosis: further experience with Japanese subjects Electroenceph Clin Neurophysiol 97 1995 S172
59. S Horn, S Quasthoff, P Grafe, H Bostock, R Renner, B Schrank Abnormal axonal inward rectification in diabetic neuropathy Muscle Nerve 19 1996 1268 1275
60. D Burke, MC Kiernan, I Mogyoros, H Bostock Differences in the properties of human sensory and motor axons J Kimura R Kaji Physiology of ALS and related diseases 1997 Elsevier Amsterdam 41 51
61. I Mogyoros, MC Kiernan, D Burke, H Bostock Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis Brain 121 1998 851 859
62. D Burke, I Mogyoros, MC Kiernan, H Bostock Excitability of cutaneous afferents in amyotrophic lateral sclerosis J Kimura R Kaji Physiology of ALS and related diseases 1997 Elsevier Amsterdam 145 154
63. MC Kiernan Impulse conduction MJ Aminoff RB Daroff Encyclopedia of the neurological sciences 2003 Academic Press San Diego, USA 639 642
64. MC Kiernan, D Burke Threshold electronus in the assessment of motor neuron disease A Eisen Handbook of clinical neurophysiology: clinical neurophysiology of motor neuron diseases 2004 Elsevier Amsterdam 359 366
65. MC Kiernan, D Burke, KV Andersen, H Bostock Multiple measures of axonal excitability: a new approach in clinical testing Muscle Nerve 23 2000 399 409
66. MC Kiernan, IK Hart, H Bostock Excitability properties of motor axons in patients with spontaneous motor unit activity J Neurol Neurosurg Psychiatry 70 2001 56 64
67. AV Krishnan, CS Lin, MC Kiernan Nerve excitability properties in lower-limb motor axons: evidence for a length-dependent gradient Muscle Nerve 29 2004 645 655
68. M de Carvalho, T Evangelista, ML Sales-Luis The corticomotor threshold is not dependent on disease duration in amyotrophic lateral sclerosis Amyotroph Lateral Scler Other Motor Neuron Disord 3 2002 39 42
69. RK Olney Transcranial magnetic stimulation: pro Amyotroph Lateral Scler Other Motor Neuron Disord 3 2002 S111
70. G Siciliano, ML Manca, L Sagliocco Cortical silent period in patients with amyotrophic lateral sclerosis J Neurol Sci 169 1999 93 97
71. A Eisen, M Swash Clinical neurophysiology of ALS Clin Neurophysiol 112 2001 2190 2201
72. M Weber, A Eisen Peristimulus time histograms (PSTHs) - a marker for upper motor neuron involvement in ALS? Amyotroph Lateral Scler Other Motor Neuron Disord 1 2000 S51 S56
73. JMC Winhammar, MC Kiernan, DB Rowe Transcranial magnetic stimulation in motor neuron disease Clin Neurophysiol 115 2004 990 993
74. BR Brooks Functional scales: summary Amyotroph Lateral Scler Other Motor Neuron Disord 3 2002 S13 S18
75. FH Norris Jr, PR Calanchini, RJ Fallat, S Panchari, B Jewett The administration of guanidine in amyotrophic lateral sclerosis Neurology 24 1974 721 728
76. G Mora Functional scales: pro Amyotroph Lateral Scler Other Motor Neuron Disord 3 2002 S9 S10
77. RJ Guiloff Functional scales in ALS: cons Amyotroph Lateral Scler Other Motor Neuron Disord 3 2002 S11 S12
78. V Appel, SS Stewart, G Smith, SH Appel A rating scale for amyotrophic lateral sclerosis: description and preliminary experience Ann Neurol 22 1987 328 333
79. PH Gordon, RG Miller, DH Moore ALSFRS-R Amyotroph Lateral Scler Other Motor Neuron Disord 5 2004 90 93
80. F Kimura, K Shinoda, S Fujiwara [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000] Rinsho Shinkeigaku 43 2003 385 391
81. ME Cudkowicz, JM Shefner, DA Schoenfeld A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis Neurology 61 2003 456 464
82. ALS CNTF Treatment Study Group A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis Neurology 46 1996 1244 1249
83. JM Cedarbaum, N Stambler Performance of the amyotrophic lateral sclerosis functional rating scale (ALSFRS) in multicenter clinical trials J Neurol Sci 152 1997 S1 S9
84. EJ Kasarskis Anthropmetrics in the assessment of muscle atrophy in amyotrophic lateral sclerosis Neurology 50 1998 A429
85. EP Pioro MR spectroscopy in amyotrophic lateral sclerosis/motor neuron disease J Neurol Sci 152 1997 S49 S53
86. S Nozaki, A Kunitomi, T Saito, T Matsumura, S Shinno [Process of swallowing disturbance in amyotrophic lateral sclerosis - evaluation of videofluorography and respiratory function] Rinsho Shinkeigaku 43 2003 77 83
87. JM Cedarbaum, N Stambler, E Malta The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function J Neurol Sci 169 1999 13 21
88. Y Ohashi, K Tashiro, Y Itoyama [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) No To Shinkei 53 2001 346 355
89. RG Miller, DH Moore 2nd, DF Gelinas Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis Neurology 56 2001 843 848
90. PN Leigh, M Swash, Y Iwasaki Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial Amyotroph Lateral Scler Other Motor Neuron Disord 5 2004 84 98
91. G Bensimon, L Lacomblez, V Meininger A controlled trial of riluzole in amyotrophic lateral sclerosis N Engl J Med 330 1994 585 591
92. L Lacomblez, G Bensimon, PN Leigh A confirmatory dose-ranging study of riluzole in ALS Neurology 47 1996 S242 S250
93. EC Lai, KJ Felice, BW Festoff Effect of recombinant human insulin-like growth factor-I on progression of ALS: a placebo-controlled study Neurology 49 1997 1621 1630
94. GD Borasio, W Robberecht, PN Leigh A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis Neurology 51 1998 583 586
95. A controlled trial of recombinant methionyl human BDNF in ALS Neurology 52 1999 1427 1433
96. RG Miller, WW Bryan, MA Dietz Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis Neurology 47 1996 1329 1331
97. RG Miller, D Moore, LA Young Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis |Neurology 47 1996 1383 1388
98. S Savas, N Delibas, C Savas, R Sutcu, A Cindas Pentoxifylline reduces biochemical markers of ischemia-reperfusion induced spinal cord injury in rabbits Spinal Cord 40 2002 224 229
99. Great Lakes ALS Study Group A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis Neurology 61 2003 1503 1507
100. L Mazzini, C Balzarini, R Colombo Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results J Neurol Sci 191 2001 139 144
101. EC Lai Therapeutic developments in amyotrophic lateral sclerosis Exp Opin Invest Drugs 8 1999 347 361
102. LJ Haverkamp, V Appel, SH Appel Natural history of amyotrophic lateral sclerosis in a database population: validation of a scoring system and a model for survival prediction Brain 118 1995 707 719
103. L Ganzini, WS Johnston, WF Hoffman Correlates of suffering in amyotrophic lateral sclerosis Neurology 52 1999 1434 1440
104. M Trail, N Nelson, JN Van, SH Appel, EC Lai Major stressors facing patients with amyotrophic lateral sclerosis (ALS): a survey to identify their concerns and to compare with those of their caregivers Amyotroph Lateral Scler Other Motor Neuron Disord 5 2004 40 45
105. A Chio, A Gauthier, A Montuschi A cross sectional study on determinants of quality of life in ALS J Neurol Neurosurg Psychiatry 75 2004 1597 1601
106. BA Bremer, AL Simone, S Walsh, Z Simmons, SH Felgoise Factors supporting quality of life over time for individuals with amyotrophic lateral sclerosis: the role of positive self-perception and religiosity Ann Behav Med 28 2004 119 125
107. C Neudert, M Wasner, GD Borasio Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis J Palliat Med 7 2004 551 557
108. RJ Fallat, B Jewitt, M Bass, B Kamm, FH Norris Jr. Spirometry in amyotrophic lateral sclerosis Arch Neurol 36 1979 74 80
109. PL Schiffman, JM Belsh Pulmonary function at diagnosis of amyotrophic lateral sclerosis: rate of deterioration Chest 103 1993 508 513
110. MI Polkey, RA Lyall, M Green, P Nigel Leigh, J Moxham Expiratory muscle function in amyotrophic lateral sclerosis Am J Respir Crit Care Med 158 1998 734 741
111. SM Kreitzer, NA Saunders, HR Tyler, RH Ingram Jr. Respiratory muscle function in amyotrophic lateral sclerosis Am Rev Respir Dis 117 1978 437 447
112. MI Polkey, M Green, J Moxham Measurement of respiratory muscle strength Thorax 50 1995 1131 1135
113. JW Fitting, R Paillex, L Hirt, P Aebischer, M Schluep Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis Ann Neurol 46 1999 887 893
114. PC Gay, PR Westbrook, JR Daube, WJ Litchy, AJ Windebank, R Iverson Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis Mayo Clin Proc 66 1991 686 694
115. WS David, SR Bundlie, Z Mahdavi Polysomnographic studies in amyotrophic lateral sclerosis J Neurol Sci 152 1997 S29 S35
116. M Vitacca, E Clini, D Facchetti Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis Eur Respir J 10 1997 1614 1621
117. RA Lyall, N Donaldson, MI Polkey, PN Leigh, J Moxham Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis Brain 124 2001 2000 2013
118. F Heritier, F Rahm, P Pasche, JW Fitting Sniff nasal inspiratory pressure: a noninvasive assessment of inspiratory muscle strength Am J Respir Crit Care Med 150 1994 1678 1683
119. MB Chaudhuri, C Liu, L Watson, D Jefferson, WJ Kinnear Sniff nasal inspiratory pressure as a marker of respiratory function in motor neuron disease Eur Respir J 15 2000 539 542
120. I Arnulf, T Similowski, F Salachas Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis Am J Respir Crit Care Med 161 2000 849 856
121. AC Pinto, T Evangelista, M Carvalho, T Paiva, M Sales-Luis Respiratory disorders in ALS: sleep and exercise studies J Neurol Sci 169 1999 61 68
122. DF Rochester, SA Esau Assessment of ventilatory function in patients with neuromuscular disease Clin Chest Med 15 1994 751 763
123. EA Oppenheimer Treating respiratory failure in ALS; the details are becoming clearer J Neurol Sci 209 2003 1 4
124. R Velasco, F Salachas, E Munerati Oxymetrie nocturne chez les patients atteints de sclerosie laterale amyotrophique: analyse de son role predictif sur la survie Rev Neurol (Paris) 158 2002 575 578
125. B Brownell, DR Oppenheimer, JT Hughes The central nervous system in motor neurone disease J Neurol Neurosurg Psychiatry 33 1970 338 357
126. PG Ince, J Evans, M Knopp Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS Neurology 60 2003 1252 1258
127. G Comi, M Rovaris, L Leocani Review neuroimaging in amyotrophic lateral sclerosis Eur J Neurol 6 1999 629 637
128. CM Ellis, A Simmonds, D Jones Diffusion tensor MRI assesses corticospinal tract damage in ALS Neurology 53 1999 1051 1058
129. G Cheung, MJ Gawel, PW Cooper, RI Farb, LC Ang, MJ Gawal Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings Radiology 194 1995 263 270
130. JW Thorpe, IF Moseley, CH Hawkes, DG MacManus, WI McDonald, DH Miller Brain and spinal cord MRI in motor neuron disease J Neurol Neurosurg Psychiatry 61 1996 314 317
131. M Waragai, H Shinotoh, M Hayashi, T Hattori High signal intensity on T1 weighted MRI of the anterolateral column of the spinal cord in amyotrophic lateral sclerosis J Neurol Neurosurg Psychiatry 62 1997 88 91
132. Y Imon, S Yamaguchi, S Katayama A decrease in cerebral cortex intensity on T2-weighted with ageing images of normal subjects Neuroradiology 40 1998 76 80
133. DS Goodin, HA Rowley, RK Olney Magnetic resonance imaging in amyotrophic lateral sclerosis Ann Neurol 23 1988 418 420
134. Segawa F KM, Kishibayashi J, Sunohara M, Shimizu Z. MRI of ALS and Wallerian degeneration: analysis of diffusion coefficient and magnetic transfer. Proceedings of Third Scientific Meeting of the International Society for Magnetic Resonance in Medicine, 1995: 1299.
135. Y Kato, K Matsumura, Y Kinosada, Y Narita, S Kuzuhara, T Nakagawa Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements AJNR Am J Neuroradiol 18 1997 1541 1547
136. PB Toft, H Leth, B Peitersen, HC Lou, C Thomsen The apparent diffusion coefficient of water in gray and white matter of the infant brain J Comput Assist Tomogr 20 1996 1006 1011
137. Wu RH BR, Berchtenbreiter C, Borrasio T, Heuck A, Reiser M. Evaluation of diffusion weighted MR-imaging in patients with ALS. Proceedings of Sixth Scientific Meeting of the International Society for Magnetic Resonance in Medicine, 1998: 1249.
138. PN Leigh, A Simmons, S Williams, V Williams, M Turner, D Brooks Imaging: MRS/MRI/PET/SPECT summary Amyotroph Lateral Scler Other Motor Neuron Disord 3 2002 S75 S80
139. B Stieltjes, WE Kaufmann, PC van Zijl Diffusion tensor imaging and axonal tracking in the human brainstem Neuroimage 14 2001 723 735
140. M Sach, G Winkler, V Glauche Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis Brain 127 2003 340 350
141. AT Toosy, DJ Werring, RW Orrell Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis J Neurol Neurosurg Psychiatry 74 2003 1250 1257
142. JJ Kew, DJ Brooks, RE Passingham, JC Rothwell, RS Frackowiak, PN Leigh Cortical function in progressive lower motor neuron disorders and amyotrophic lateral sclerosis: a comparative PET study Neurology 44 1994 1101 1110
143. EP Pioro, JP Antel, NR Cashman, DL Arnold Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo Neurology 44 1994 1933 1938
144. AP Jones, WJ Gunawardena, CM Coutinho, JA Gatt, IC Shaw, JD Mitchell Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amyotrophic lateral sclerosis) J Neurol Sci 129 1995 85 89
145. O Gredal, S Rosenbaum, S Topp, M Karlsborg, P Strange, L Werdelin Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy Neurology 48 1997 878 881
146. CM Ellis, A Simmons, C Andrews, JM Dawson, SC Williams, PN Leigh A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings Neurology 51 1998 1104 1109
147. W Block, J Karitzky, F Traber Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease Arch Neurol 55 1998 931 936
148. MF Weiner Alzheimer's disease: diagnosis and treatment Harv Rev Psychiatry 4 1997 306 316
149. P Kaufmann, H Mitsumoto Amyotrophic lateral sclerosis: objective upper motor neuron markers Curr Neurol Neurosci Rep 2 2002 55 60
150. P Kaufmann, SL Pullman, DC Shungu Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS) Neurology 62 2004 1753 1757
151. EP Simpson, YK Henry, JS Henkel, RG Smith, SH Appel Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden Neurology 62 2004 1758 1765
152. JS Henkel, JI Engelhardt, L Siklos Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue Ann Neurol 55 2004 221 235
153. L Dupuis, JL Gonzalez de Aguilar, F di Scala Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis Neurobiol Dis 10 2002 358 365
154. F Dangond, D Hwang, S Camelo Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter Physiol Genomics 16 2004 229 239
155. Y Tang, A Lu, BJ Aronow, FR Sharp Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease Ann Neurol 50 2001 699 707